Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 624

1.

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.

Armangue T, Olivé-Cirera G, Martínez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Muñoz-Batista M, Ariño H, González-Álvarez V, Felipe-Rucián A, Jesús Martínez-González M, Cantarín-Extremera V, Concepción Miranda-Herrero M, Monge-Galindo L, Tomás-Vila M, Miravet E, Málaga I, Arrambide G, Auger C, Tintoré M, Montalban X, Vanderver A, Graus F, Saiz A, Dalmau J; Spanish Pediatric anti-MOG Study Group.

Lancet Neurol. 2020 Mar;19(3):234-246. doi: 10.1016/S1474-4422(19)30488-0. Epub 2020 Feb 10.

PMID:
32057303
2.

N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function.

Matute C, Palma A, Serrano-Regal MP, Maudes E, Barman S, Sánchez-Gómez MV, Domercq M, Goebels N, Dalmau J.

Ann Neurol. 2020 Feb 12. doi: 10.1002/ana.25699. [Epub ahead of print]

PMID:
32052483
3.

How DIRS is refining concepts.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 7;7(2). pii: e677. doi: 10.1212/NXI.0000000000000677. Print 2020 Mar 5. No abstract available.

4.

Clinical significance of Kelch-like protein 11 antibodies.

Maudes E, Landa J, Muñoz-Lopetegi A, Armangue T, Alba M, Saiz A, Graus F, Dalmau J, Sabater L.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 17;7(3). pii: e666. doi: 10.1212/NXI.0000000000000666. Print 2020 May.

5.

Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient.

Cellucci T, Van Mater H, Graus F, Muscal E, Gallentine W, Klein-Gitelman MS, Benseler SM, Frankovich J, Gorman MP, Van Haren K, Dalmau J, Dale RC.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 17;7(2). pii: e663. doi: 10.1212/NXI.0000000000000663. Print 2020 Mar.

6.

Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series.

Joubert B, García-Serra A, Planagumà J, Martínez-Hernandez E, Kraft A, Palm F, Iizuka T, Honnorat J, Leypoldt F, Graus F, Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 16;7(3). pii: e668. doi: 10.1212/NXI.0000000000000668. Print 2020 May.

7.

Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)".

Dalmau J.

Stroke. 2020 Feb;51(2):e28. doi: 10.1161/STROKEAHA.119.027885. Epub 2020 Jan 13. No abstract available.

PMID:
31928149
8.

Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis.

Guasp M, Módena Y, Armangue T, Dalmau J, Graus F.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 3;7(2). pii: e659. doi: 10.1212/NXI.0000000000000659. Print 2020 Mar.

9.

Considerations of psychotic symptomatology in anti-NMDA encephalitis: Similarity to cycloid psychosis.

Giné Servén E, Boix Quintana E, Guanyabens Buscà N, Casado Ruiz V, Torres Rivas C, Niubo Gurgui M, Dalmau J, Palma C.

Clin Case Rep. 2019 Nov 7;7(12):2456-2461. doi: 10.1002/ccr3.2522. eCollection 2019 Dec.

10.

Hashimoto encephalopathy in the 21st century.

Mattozzi S, Sabater L, Escudero D, Ariño H, Armangue T, Simabukuro M, Iizuka T, Hara M, Saiz A, Sotgiu S, Dalmau J, Graus F.

Neurology. 2020 Jan 14;94(2):e217-e224. doi: 10.1212/WNL.0000000000008785. Epub 2019 Dec 27.

PMID:
31882532
11.

Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis.

Sola-Valls N, Ariño H, Escudero D, Solana E, Lladó A, Sánchez-Valle R, Blanco Y, Saiz A, Dalmau J, Graus F.

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 17;7(2). pii: e652. doi: 10.1212/NXI.0000000000000652. Print 2020 Mar.

12.

Dietary practices in methylmalonic acidaemia: a European survey.

Pinto A, Evans S, Daly A, Almeida MF, Assoun M, Belanger-Quintana A, Bernabei SM, Bollhalder S, Cassiman D, Champion H, Chan H, Corthouts K, Dalmau J, Boer F, Laet C, Meyer A, Desloovere A, Dianin A, Dixon M, Dokoupil K, Dubois S, Eyskens F, Faria A, Fasan I, Favre E, Feillet F, Fekete A, Gallo G, Gingell C, Gribben J, Hansen KK, Horst NT, Jankowski C, Janssen-Regelink R, Jones I, Jouault C, Kahrs GE, Kok I, Kowalik A, Laguerre C, Verge SL, Liguori A, Lilje R, Maddalon C, Mayr D, Meyer U, Micciche A, Och U, Robert M, Rocha JC, Rogozinski H, Rohde C, Ross K, Saruggia I, Schlune A, Singleton K, Sjoqvist E, Skeath R, Stolen LH, Terry A, Timmer C, Tomlinson L, Tooke A, Kerckhove KV, van Dam E, Hurk DVD, Ploeg LV, van Driessche M, van Rijn M, Wegberg AV, Vasconcelos C, Vestergaard H, Vitoria I, Webster D, White F, White L, Zweers H, MacDonald A.

J Pediatr Endocrinol Metab. 2020 Jan 28;33(1):147-155. doi: 10.1515/jpem-2019-0277.

PMID:
31846426
13.

N2 year in review.

Dalmau J, Dalakas MC, Kolson DL, Paul F, Zamvil SS.

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 12;7(1). pii: e644. doi: 10.1212/NXI.0000000000000644. Print 2020 Jan. No abstract available.

14.

Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2.

Ruiz-García R, Martínez-Hernández E, Joubert B, Petit-Pedrol M, Pajarón-Boix E, Fernández V, Salais L, Del Pozo M, Armangué T, Sabater L, Dalmau J, Graus F.

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 11;7(2). pii: e658. doi: 10.1212/NXI.0000000000000658. Print 2020 Mar.

15.

Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab.

Blanch-Lombarte O, Gálvez C, Revollo B, Jiménez-Moyano E, Llibre JM, Manzano JL, Boada A, Dalmau J, E Speiser D, Clotet B, Prado JG, Martinez-Picado J.

J Clin Med. 2019 Dec 1;8(12). pii: E2089. doi: 10.3390/jcm8122089.

16.

Pregnancy, N-Methyl-D-Aspartate Receptor Antibodies, and Neuropsychiatric Diseases.

Dalmau J.

Ann Neurol. 2020 Feb;87(2):324-325. doi: 10.1002/ana.25654. Epub 2019 Dec 10. No abstract available.

PMID:
31782163
17.

Learning from adverse treatment effects.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 28;6(6):e630. doi: 10.1212/NXI.0000000000000630. Print 2019 Nov. No abstract available.

18.

Toll-like receptor 3 deficiency in autoimmune encephalitis post-herpes simplex encephalitis.

Armangue T, Baucells BJ, Vlagea A, Petit-Pedrol M, Esteve-Solé A, Deyà-Martínez A, Ruiz-García R, Juan M, Pérez de Diego R, Dalmau J, Alsina L.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 5;6(6). pii: e611. doi: 10.1212/NXI.0000000000000611. Print 2019 Nov. No abstract available.

19.

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.

Sepulveda M, Delgado-García G, Blanco Y, Sola-Valls N, Martinez-Lapiscina EH, Armangué T, Montejo C, Pulido-Valdeolivas I, Martinez-Hernandez E, Ariño H, Escudero D, Ruiz-García R, Llufriu S, Dalmau J, Graus F, Saiz A.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 30;6(6). pii: e607. doi: 10.1212/NXI.0000000000000607. Print 2019 Nov.

20.

Neurofilament light chain levels in MS: At the doorstep of clinical application.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5). pii: e601. doi: 10.1212/NXI.0000000000000601. Print 2019 Sep. No abstract available.

21.

Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.

Carrera-García L, Natera-de Benito D, Lleixà C, Ortez C, Colomer J, Nascimento A, Saiz A, Dalmau J, Querol L, Armangué T.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 24;6(5). pii: e602. doi: 10.1212/NXI.0000000000000602. Print 2019 Sep. No abstract available.

22.

HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease.

Gaig C, Ercilla G, Daura X, Ezquerra M, Fernández-Santiago R, Palou E, Sabater L, Höftberger R, Heidbreder A, Högl B, Iranzo A, Santamaria J, Dalmau J, Graus F.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 12;6(6). pii: e605. doi: 10.1212/NXI.0000000000000605. Print 2019 Nov.

23.

The role of infections in autoimmune encephalitides.

Joubert B, Dalmau J.

Rev Neurol (Paris). 2019 Sep - Oct;175(7-8):420-426. doi: 10.1016/j.neurol.2019.07.004. Epub 2019 Jul 29. Review.

PMID:
31371185
24.

Time is tissue in optic neuritis.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 5;6(4):e578. doi: 10.1212/NXI.0000000000000578. eCollection 2019 Jul. No abstract available.

25.

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F.

Lancet Neurol. 2019 Nov;18(11):1045-1057. doi: 10.1016/S1474-4422(19)30244-3. Epub 2019 Jul 17. Review.

PMID:
31326280
26.

Characterization of the sleep disorder of anti-IgLON5 disease.

Gaig C, Iranzo A, Cajochen C, Vilaseca I, Embid C, Dalmau J, Graus F, Santamaria J.

Sleep. 2019 Jun 14. pii: zsz133. doi: 10.1093/sleep/zsz133. [Epub ahead of print]

PMID:
31198936
27.

Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: Three new cases and a review of the literature.

Bien CI, Nehls F, Kollmar R, Weis M, Steinke W, Woermann F, Dalmau J, Bien CG.

J Neuroimmunol. 2019 Sep 15;334:576975. doi: 10.1016/j.jneuroim.2019.576975. Epub 2019 May 29.

PMID:
31177032
28.

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.

Ruiz-García R, Martínez-Hernández E, García-Ormaechea M, Español-Rego M, Sabater L, Querol L, Illa I, Dalmau J, Graus F.

Front Immunol. 2019 Apr 12;10:769. doi: 10.3389/fimmu.2019.00769. eCollection 2019.

29.

Recognizing autoimmune encephalitis as a cause of seizures: Treating cause and not effect.

Britton JW, Dalmau J.

Neurology. 2019 May 7;92(19):877-878. doi: 10.1212/WNL.0000000000007444. Epub 2019 Apr 12. No abstract available.

PMID:
30979858
30.

Betaine anhydrous in homocystinuria: results from the RoCH registry.

Valayannopoulos V, Schiff M, Guffon N, Nadjar Y, García-Cazorla A, Martinez-Pardo Casanova M, Cano A, Couce ML, Dalmau J, Peña-Quintana L, Rigalleau V, Touati G, Aldamiz-Echevarria L, Cathebras P, Eyer D, Brunet D, Damaj L, Dobbelaere D, Gay C, Hiéronimus S, Levrat V, Maillot F.

Orphanet J Rare Dis. 2019 Mar 14;14(1):66. doi: 10.1186/s13023-019-1036-2.

31.

Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors.

Graus F, Dalmau J.

Nat Rev Clin Oncol. 2019 Sep;16(9):535-548. doi: 10.1038/s41571-019-0194-4. Review.

PMID:
30867573
32.

Rectifying neurologic diagnosis through autoantibodies.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 14;6(2):e540. doi: 10.1212/NXI.0000000000000540. eCollection 2019 Mar. No abstract available.

33.

Seizures and movement disorders: phenomenology, diagnostic challenges and therapeutic approaches.

Freitas ME, Ruiz-Lopez M, Dalmau J, Erro R, Privitera M, Andrade D, Fasano A.

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):920-928. doi: 10.1136/jnnp-2018-320039. Epub 2019 Feb 22. Review.

PMID:
30796133
34.

Iceberg sign as a dermoscopic clue of actinic keratosis neglecta.

Mir-Bonafé JF, Rozas-Muñoz E, Dalmau J, Mir-Bonafé M, Iznardo H, García-Melendo C, Puig L.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):e254-e256. doi: 10.1111/jdv.15484. Epub 2019 Apr 15. No abstract available.

PMID:
30742717
35.

Autoimmune seizures and epilepsy.

Geis C, Planagumà J, Carreño M, Graus F, Dalmau J.

J Clin Invest. 2019 Mar 1;129(3):926-940. doi: 10.1172/JCI125178. Epub 2019 Feb 4. Review.

36.

Mouse model of anti-NMDA receptor post-herpes simplex encephalitis.

Linnoila J, Pulli B, Armangué T, Planagumà J, Narsimhan R, Schob S, Zeller MWG, Dalmau J, Chen J.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 26;6(2):e529. doi: 10.1212/NXI.0000000000000529. eCollection 2019 Mar.

37.

N2 year in review and message from the editor to our reviewers.

Dalmau J, Kolson DL, Paul F, Zamvil SS.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 19;6(1):e525. doi: 10.1212/NXI.0000000000000525. eCollection 2019 Jan. No abstract available.

38.

Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.

Pedreño M, Sepúlveda M, Armangué T, Sabater L, Martínez-Hernandez E, Arrambide G, Blanco Y, Llufriu S, Martínez-Lapiscina EH, Mulero P, Sola-Valls N, Ruiz-García R, Tintoré M, Dalmau J, Graus F, Saiz A.

Mult Scler Relat Disord. 2019 Feb;28:230-234. doi: 10.1016/j.msard.2019.01.007. Epub 2019 Jan 3.

PMID:
30623863
39.

A Shiny Nodule on the Forehead of a Man.

Mir-Bonafé JF, Dalmau J, Rozas-Muñoz E.

Actas Dermosifiliogr. 2019 Oct;110(8):681-682. doi: 10.1016/j.ad.2018.04.008. Epub 2019 Jan 2. English, Spanish. No abstract available.

PMID:
30611395
40.

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.

Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2019 Jan 15;92(3):e244-e252. doi: 10.1212/WNL.0000000000006783. Epub 2018 Dec 21.

41.

Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.

Matas-Nadal C, Malvehy J, Ferreres JR, Boada A, Bodet D, Segura S, Salleras M, Azon A, Bel-Pla S, Bigata X, Campoy A, Curcó N, Dalmau J, Formigon M, Gonzalez A, Just M, Llistosella E, Nogues ME, Pedragosa R, Pujol JA, Sabat M, Smandia JA, Zaballos P, Puig S, Martí RM.

Int J Dermatol. 2019 May;58(5):577-581. doi: 10.1111/ijd.14334. Epub 2018 Dec 13.

PMID:
30548854
42.

Diagnostic and treatment challenges, a new section in N2.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 23;5(6):e511. doi: 10.1212/NXI.0000000000000511. eCollection 2018 Nov. No abstract available.

43.

Author Correction: Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Dec;14(12):749. doi: 10.1038/s41582-018-0077-9.

PMID:
30442924
44.

Importance of clinical observations.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2018 Feb 2;5(2):e442. doi: 10.1212/NXI.0000000000000442. eCollection 2018 Mar. No abstract available.

45.

Validation of motion perception of briefly displayed images using a tablet.

Linares D, Marin-Campos R, Dalmau J, Compte A.

Sci Rep. 2018 Oct 30;8(1):16056. doi: 10.1038/s41598-018-34466-9.

46.

LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.

Petit-Pedrol M, Sell J, Planagumà J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D, Gasull X, Dalmau J, Geis C.

Brain. 2018 Nov 1;141(11):3144-3159. doi: 10.1093/brain/awy253.

47.

Acute disseminated encephalomyelitis: A rare autoimmune complication of herpes simplex encephalitis in the adult.

Bocos-Portillo J, Sánchez-Menoyo JL, Beldarrain MG, Saralegui Prieto I, Ontañón Garcés JM, Dalmau J, García-Moncó JC.

Clin Neurol Neurosurg. 2018 Dec;175:47-49. doi: 10.1016/j.clineuro.2018.10.007. Epub 2018 Oct 9. No abstract available.

PMID:
30336448
48.

Of primary and secondary CNS autoimmunity.

Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(5):e494. doi: 10.1212/NXI.0000000000000494. eCollection 2018 Sep. No abstract available.

49.

Human Autoantibodies against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction.

Haselmann H, Mannara F, Werner C, Planagumà J, Miguez-Cabello F, Schmidl L, Grünewald B, Petit-Pedrol M, Kirmse K, Classen J, Demir F, Klöcker N, Soto D, Doose S, Dalmau J, Hallermann S, Geis C.

Neuron. 2018 Oct 10;100(1):91-105.e9. doi: 10.1016/j.neuron.2018.07.048. Epub 2018 Aug 23.

50.

Paraneoplastic Neurologic Syndromes.

Rosenfeld MR, Dalmau J.

Neurol Clin. 2018 Aug;36(3):675-685. doi: 10.1016/j.ncl.2018.04.015. Epub 2018 Jun 18. Review.

PMID:
30072076

Supplemental Content

Loading ...
Support Center